Agenus | AGEN - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 82.99M 2.3M 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celldex Therapeutics USD 1.18M 3.09M 2025-12
CSL USD 3.17B 290M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 11.99B 2.37B 2025-12
Jiangsu Hengrui CNY 2.22B 25.33M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
MacroGenics USD 4.79M 1.15M 2025-12
Merck EUR 2.11B 182M 2025-12
Merck USD 4.15B 102M 2025-09
Northwest Biotherapeutics 27.22M 5.8M 2025-03
Novartis USD 4.46B 99M 2025-12
Novavax USD 24.58M 9.35M 2025-12
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Veracyte USD 4.59M 916K 2025-12